Features - Tropical diseases


Current filters:

Tropical diseases

Popular Filters

51 to 75 of 83 results

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products


UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Sanofi and PATH launch large-scale production of semi-synthetic artemisinin in Italy


French drug major Sanofi (Euronext: SAN) and non-profit global health organization PATH's Drug Development…

artemisininPharmaceuticalProductionSanofiTropical diseases

News briefs: Novartis drops Ruvise MAA; B-MS settlement; Germany donates to Global Fund


The European Medicines Agency says it has been formally notified by Swiss drug major Novartis (NOVN:…

Anti-viralsBMS-986094Bristol-Myers SquibbFinancialLegalNovartisPharmaceuticalRare diseasesRegulationRuviseTropical diseases

New executive director of the Global Fund outlines ambitious agenda


Mark Dybul yesterday took charge as executive director of the Global Fund to Fight AIDS, Tuberculosis…

Anti-viralsAntibiotics and Infectious diseasesFinancialManagementPharmaceuticalTropical diseases

New report shows major increase in pharmaceutical R&D for neglected diseases


R&D, health system capacity-strengthening efforts, and medicine donations comprise the pharmaceutical…

GlobalPharmaceuticalRare diseasesResearchTropical diseases

PATH MVI links with Inovio on malaria vaccines and delivery technology


The USA-based PATH Malaria Vaccine Initiative (MVI) has announced a follow-on collaboration with drugmaker…

Inovio PharmaceuticalsPharmaceuticalResearchTropical diseasesVaccines

New report signals slowdown in the fight against malaria


During the past decade, a concerted effort by endemic countries, donors and global malaria partners led…

FinancialHealthcarePharmaceuticalTropical diseases

Time for government action on investing in neglected diseases R&D


A five-year review of global neglected disease R&D funding shows that, despite increased investment of…

FinancialPharmaceuticalRare diseasesResearchTropical diseases

Astellas collaborates with AIST for neglected tropical diseases


Japanese drug major Astellas Pharma (TYO: 4503) has signed a collaborative drug discovery research agreement…

Asia-PacificAstellas PharmaPharmaceuticalResearchTropical diseases

Astellas links with KEK on tropical diseases; Upgraded by CS analysts


Japanese drug major Astellas Pharma (TYO: 4503) has entered into a collaboration with the High Energy…

Astellas PharmaFinancialGenito-urinaryMyrbetriqOncologyPharmaceuticalResearchTropical diseasesXtandi

Eisai's Fycompa gets first EU launch, in UK; links with Sabine Vaccine Inst


Japanese drug major Eisai (TYO: 4523) has announced the first European launch today of Fycompa (perampanel),…

EisaiFycompaMarkets & MarketingNeurologicalPharmaceuticalResearchTropical diseasesVaccines

Astellas and Tokyo-Tech collaborate on neglected disease research


The Tokyo Institute of Technology (Tokyo-Tech) and Japanese drug major Astellas Pharma (TYO: 4503) have…

Astellas PharmaPharmaceuticalRare diseasesResearchTropical diseases

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations


French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Novavax and Cadila in public/private malaria vaccine collaboration


USA-based clinical-stage firm Novavax (Nasdaq: NVAX), CPL Biologicals (CPLB) - a joint-venture biotechnology…

Cadila PharmaceuticalsCPL BiologicalsNovavaxPharmaceuticalResearchTropical diseasesVaccines

New public-private partnership to develop a treatment for schistosomiasis-infected pre-school children


A newly established international public-private partnership (PPP) between the Dutch non-profit organization…

Astellas PharmaMerck KGaAMerck SeronoPharmaceuticalpraziquantelResearchTropical diseases

Astellas enters neglected tropical diseases drug discovery scene in partnership with DNDi


As a first critical step of its new strategy to enter into the field of neglected tropical diseases (NTD)…

Astellas PharmaPharmaceuticalResearchTropical diseases

Scientists say new process would make anti-malarial drug less costly


Scientists are reporting development of a new, higher-yield, two-step, less costly process that may ease…

artemisininGenericsPricingResearchTropical diseases

Ranbaxy debuts first Indian-developed malaria drug, Synriam


Indian drug major Ranbaxy (AB: B) said yesterday - coinciding with World Malaria Day - that it is "opening…

Asia-PacificDaiichi SankyoMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSynriamTropical diseases

Dundee, GSK and Wellcome Trust collaborate for neglected diseases


The University of Dundee, UK, has received over ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������£10…

FinancialGlaxoSmithKlinePharmaceuticalResearchTropical diseases

Research-based pharma pledges on neglected tropical diseases


The research-based pharmaceutical industry has announced donations of 14 billion treatments this decade…

FinancialGlobalPharmaceuticalResearchTropical diseases

Fake drugs dashing hopes of controlling malaria in Africa


The emergence of fake and poor quality anti-malarial drugs could dash hopes of controlling malaria in…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldTropical diseases

51 to 75 of 83 results

Back to top